Farmak International Finalizes Integration of Symphar, Poland
Farmak International has finalized the full integration of Symphar Sp. z o.o. into its international business structure.
Effective April 1, 2025, all Polish operations will be consolidated under a single legal entity: Farmak International Sp. z o.o.
This follows the March 27, 2024, acquisition of Symphar by Farmak AG, which marked a significant expansion of the Group’s footprint in the Central and Eastern European (CEE) pharmaceutical market. Over the past 12 months, both Farmak International Sp. z o.o. and Symphar Sp. z o.o. operated in parallel while a structured integration process was implemented. The legal and operational merger is now complete.
With this consolidation, we’ve moved from strategic acquisition to full operational alignment in Poland. The integration enables us to unlock synergies, simplify market interactions, and scale more efficiently in the European territory. This is a critical enabler for growth, not just in Poland, but across the CEE region.
Viktor Kostiuk CEO of Farmak International
Poland is one of Farmak International’s most mature European markets, with a strong commercial portfolio and local expertise built over a decade of activity. Farmak Group entered the Polish market in 2015 with the acquisition of Nordfarm Sp. z o.o, and in 2024 significantly reinforced its presence with the acquisition of Symphar Sp. z o.o. Today, Farmak International in Poland manages over 40 brands, focused in key therapeutic areas: Allergology, Diabetology, Psychiatry, Gastroenterology, Pain, Probiotics, and Cough & Cold
We’ve operated successfully in Poland for nearly a decade with strong commercial teams and deep market know-how. Bringing everything under one roof sharpens our market focus and creates a leaner structure for decision-making, partnership development, and portfolio growth.”
Paulina Romaniszyn Head of Central and Eastern Europe
This integration ensures a more agile business model in Poland, enhances service continuity for partners and distributors, and strengthens Farmak International’s long-term strategy in the region.
About Farmak Group and Farmak International
Farmak Group is a global pharmaceutical business tracing its roots to Ukraine since 1925, with production facilities in two countries in Europe, and 13 companies and international offices in Poland, the Czech Republic, Slovakia, the United Kingdom, the UAE, Vietnam, Switzerland, Kazakhstan, Uzbekistan, Kyrgyzstan, Moldova, Spain, and Ukraine. The products of Farmak Group are exported to 60 countries worldwide, spanning key regions including Europe, Asia, the Middle East and Africa (MEA), and Latin America.
Farmak International, a brand managed by FARMAK AG, headquartered in Switzerland, leads the Farmak Group’s global strategy, overseeing business operations, asset management, and expansion into international markets. It oversees and manages the entities established to conduct business under Farmak International brand in Switzerland, Spain, Poland, the Czech Republic, Slovakia, the United Kingdom, the UAE, and by representative office in Vietnam.
For inquiries, please contact:
info@farmak.ch
